In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Chembio Diagnostics Inc.

Latest From Chembio Diagnostics Inc.

M&A Analysis: November Deal Making Hits Whole New Low

M&A deal activity dropped dramatically in November with a mere six deals in the medtech industry, making November the weakest month of the year so far. The biggest deal of the month recorded was Edward Lifesciences $690m acquisition of Israeli start-up Valtech.

M & A Deals

Chembio Wins $13.2M US BARDA Contract To Develop POC Zika Tests

HHS and its subagency Biomedical Advanced Research and Development Authority (BARDA) has put together additional funding to award Chembio Diagnostic Systems $13.2m to develop and commercialize the firm's rapid point-of-care Zika test, a mere two weeks after the agency said it only had enough funds for Zika vaccine development.

United States Medical Device

CMS To Expand Screening Coverage For HIV, HPV

CMS took steps to expand coverage for two infectious diseases: a final decision memo to cover screening for human immunodeficiency virus irrespective of risk and a proposal to cover human papillomavirus screens in combination with Pap smears for women aged 30 to 65.

Medical Device Reimbursement

Medtech Execs On The Move, February 2015

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Alias(es)
  • Trading Solutions
  • Chembio Diagnostic Systems Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Chembio Diagnostics Inc.
  • Senior Management
  • John Sperzel, Pres. & CEO
    Neil A Goldman, EVP, CFO
    Javan Esfandiari , EVP, CSO & CTO
    David Gyorke, SVP, COO
    Robert Passas, PhD, SVP, Chief Commercial Officer
  • Contact Info
  • Chembio Diagnostics Inc.
    Phone: (631) 924-1135
    3661 Horseblock Rd.
    Medford, NY 11763